4
Changes in Ownership
SELLAS Life Sciences Group, Inc. Filed Acc 0001390478-15-000004
VP, Chief Financial Officer acquired 3,846 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dunlap Ryan VP, Chief Financial Officer | 2014-12-31 | Other acquisition | +3,846 | $1.28 | $4,923 | 11,650 | D |
| Derivatives | |||||||
| Dunlap Ryan VP, Chief Financial Officer | 2015-01-16 | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | D | ||
Loading xslF345X03/primary_doc.xml…